Annals of Medicine and Surgery最新文献

筛选
英文 中文
Mechanical thrombectomy by stent retriever for the treatment of arterial ischemic stroke in a pediatric patient with acute lymphoblastic leukemia: a case report. 支架回收器机械取栓治疗急性淋巴细胞白血病儿童动脉缺血性脑卒中1例报告。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-21 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002680
Arash Khameneh Bagheri, Mitra Khalili, Samin Alavi, Zahra Khaffafpour, Mehdi Aghapour, Alireza Zamani, Paniz Mirmoghaddam
{"title":"Mechanical thrombectomy by stent retriever for the treatment of arterial ischemic stroke in a pediatric patient with acute lymphoblastic leukemia: a case report.","authors":"Arash Khameneh Bagheri, Mitra Khalili, Samin Alavi, Zahra Khaffafpour, Mehdi Aghapour, Alireza Zamani, Paniz Mirmoghaddam","doi":"10.1097/MS9.0000000000002680","DOIUrl":"10.1097/MS9.0000000000002680","url":null,"abstract":"<p><strong>Introduction: </strong>Arterial ischemic stroke (AIS) caused by occlusion of large vessels in childhood is a devastating rare condition that can contribute to long-term disabilities. Childhood leukemia is identified as a recognized risk factor for ischemic strokes. Mechanical thrombectomy is the standard of care for large vessel occlusions in adults. However, there are still no definite recommendations regarding the application and outcomes of endovascular thrombectomy and the devices used for pediatric patients with arterial ischemic stroke.</p><p><strong>Case presentation: </strong>The authors report a 13-year-old female with acute lymphoblastic leukemia who developed AIS due to thrombosis in the left internal carotid and proximal middle cerebral artery in the induction phase of treatment. The patient underwent successful mechanical thrombectomy via Solumbra by using \"Embolus Retriever with Interlinked Cages (ERIC)\" stent retriever and Sofia plus catheter, which resulted in successful recanalization of ICA and MCA.</p><p><strong>Discussion: </strong>Selected pediatric patients with AIS due to large vessel occlusions can benefit from mechanical thrombectomy. Although the recently published literature demonstrated the efficacy and safety of MT in children, strong guideline recommendations are still absent. At present, the last AHA/ASA guidelines for early management of AIS recommends intravenous thrombolysis and endovascular therapy in adults, whereas controversy still exists in children. An urgent approach within the defined therapeutic time frame and a multidisciplinary team specialized in pediatric stroke with professionally trained interventional neuroradiologist is essential for achieving optimal results.</p><p><strong>Conclusion: </strong>Mechanical thrombectomy provides promising results with high rates of arterial recanalization and favorable outcomes in pediatric patients with AIS.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7402-7407"},"PeriodicalIF":1.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The paradox of Helicobacter pylori: how does H. pylori infection protect against esophageal cancer? 幽门螺杆菌的悖论:幽门螺杆菌感染如何预防食道癌?
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-21 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002674
Erfan Banisefid, Ehsan Nasiri, Seyedyashar Pourebrahimian Leilabadi, Sina Hamzehzadeh, Mohammad Amin Akbarzadeh, Mohammad-Salar Hosseini
{"title":"The paradox of <i>Helicobacter pylori</i>: how does <i>H. pylori</i> infection protect against esophageal cancer?","authors":"Erfan Banisefid, Ehsan Nasiri, Seyedyashar Pourebrahimian Leilabadi, Sina Hamzehzadeh, Mohammad Amin Akbarzadeh, Mohammad-Salar Hosseini","doi":"10.1097/MS9.0000000000002674","DOIUrl":"10.1097/MS9.0000000000002674","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> is a microaerophilic gram-negative bacterium infecting around half of the world's population. Despite its well-known role in gastric malignancies, its impact on esophageal cancer comes with a complex paradox. Several mechanisms have been proposed to explain its observed lack of carcinogenic activity in the esophagus, including the trigger of anti-inflammatory pathways, promoting atrophic gastritis, and esophageal microbiome modulation. However, recent studies have highlighted a significantly more complicated interplay, where <i>H. pylori</i>, typically considered a pathogen, may even deliver a protective effect against esophageal carcinogenesis. This paper aims to evaluate the prevalence of <i>H. pylori</i> infection among patients with esophageal carcinoma, discussing the underlying mechanisms of the paradoxical effects of <i>H. pylori</i> on esophageal cancer.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7221-7226"},"PeriodicalIF":1.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging trends and hotspots in lung cancer-prediction models research. 肺癌预测模型研究的新趋势与热点
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-18 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002648
Qiong Ma, Hua Jiang, Shiyan Tan, Fengming You, Chuan Zheng, Qian Wang, Yifeng Ren
{"title":"Emerging trends and hotspots in lung cancer-prediction models research.","authors":"Qiong Ma, Hua Jiang, Shiyan Tan, Fengming You, Chuan Zheng, Qian Wang, Yifeng Ren","doi":"10.1097/MS9.0000000000002648","DOIUrl":"10.1097/MS9.0000000000002648","url":null,"abstract":"<p><strong>Objective: </strong>In recent years, lung cancer-prediction models have become popular. However, few bibliometric analyses have been performed in this field.</p><p><strong>Methods: </strong>This study aimed to reveal the scientific output and trends in lung cancer-prediction models from a global perspective. In this study, publications were retrieved and extracted from the Web of Science Core Collection (WoSCC) database. CiteSpace 6.1.R3 and VOSviewer 1.6.18 were used to analyze hotspots and theme trends.</p><p><strong>Results: </strong>A marked increase in the number of publications related to lung cancer-prediction models was observed. A total of 2711 institutions from in 64 countries/regions published 2139 documents in 566 academic journals. China and the United States were the leading country in the field of lung cancer-prediction models. The institutions represented by Fudan University had significant academic influence in the field. Analysis of keywords revealed that lncRNA, tumor microenvironment, immune, cancer statistics, The Cancer Genome Atlas, nomogram, and machine learning were the current focus of research in lung cancer-prediction models.</p><p><strong>Conclusions: </strong>Over the last two decades, research on risk-prediction models for lung cancer has attracted increasing attention. Prognosis, machine learning, and multi-omics technologies are both current hotspots and future trends in this field. In the future, in-depth explorations using different omics should increase the sensitivity and accuracy of lung cancer-prediction models and reduce the global burden of lung cancer.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7178-7192"},"PeriodicalIF":1.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric glomus tumor with a rare presentation: a case report and review of the literature. 胃球囊瘤的罕见表现:一个病例报告和文献复习。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-17 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002659
Mariam Mohammed Thalji, Yousef A Alnajjar, Maen Mohammad, Hala Khadra, Sami Bannoura, Hazem Al-Ashhab
{"title":"Gastric glomus tumor with a rare presentation: a case report and review of the literature.","authors":"Mariam Mohammed Thalji, Yousef A Alnajjar, Maen Mohammad, Hala Khadra, Sami Bannoura, Hazem Al-Ashhab","doi":"10.1097/MS9.0000000000002659","DOIUrl":"10.1097/MS9.0000000000002659","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Gastric glomus tumors (GGT) are rare soft tissue tumors of the gastrointestinal tracts (GIT). It is somewhat challenging to establish the diagnosis of GGT and differentiate it from the more common submucosal neoplasms.</p><p><strong>Case presentation: </strong>A 34-year-old female patient presented with upper gastrointestinal bleeding. Extensive workup including endoscopic ultrasonography (EUS) revealed a well-circumscribed isoechoic mass arising from the muscularis propria. Based on fine needle biopsy (FNB) findings, with H&E stains performed only initially, the mass was considered a neuroendocrine tumor (NET). Antrectomy with Billroth II anastomosis was performed. A microscopic and immunohistochemical studies of the resected specimen showed the cells to be positive for smooth muscle actin (SMA) making GGT the final diagnosis.</p><p><strong>Clinical discussion: </strong>Of the 116 patients included in our analysis, 56.9% (<i>n</i>=66) were females and age group was between 41 and 64 years old in 63.8% (<i>n</i>=74) of the patients. About 55 cases (47.4%) had abdominal or epigastric pain or discomfort, which was the most frequent clinical symptom. In immunohistochemistry, SMA staining is present in 68.1% of the cases, underscoring its diagnostic significance. Laparotomy with wedge or partial gastrectomy was employed in 46.1% of the recorded cases. Due to malignant potential, long-term follow-up and monitoring are usually recommended.</p><p><strong>Conclusion: </strong>Despite the rarity of GGT, they should be included in the differential diagnosis of gastric submucosal tumors, with immunohistochemistry studies playing a major role in the diagnosis. Furthermore, a comprehensive evaluation of the literature in the past 8 years was presented in a table.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7356-7361"},"PeriodicalIF":1.7,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An associate of suspicious axillary node and sentinel node in breast cancer to minimizing axillary surgery, prospective cohort study. 乳腺癌可疑腋窝淋巴结和前哨淋巴结与减少腋窝手术的关联,前瞻性队列研究。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-17 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002616
Prakasit Chirappapha, Panuwat Lertsithichai, Lakkana Adireklarpwong, Supanat Kaeosuwan, Cholatip Wiratkapun, Sarunthorn Lapkittichot, Navalee Taerakul, Muntana Trimankha, Kanitha Nimitkul, Wiriya Pipatsakulroj, Thongchai Sukarayothin, Monchai Leesombatpaiboon, Ronnarat Suvikapakornkul, Yodying Wasuthit
{"title":"An associate of suspicious axillary node and sentinel node in breast cancer to minimizing axillary surgery, prospective cohort study.","authors":"Prakasit Chirappapha, Panuwat Lertsithichai, Lakkana Adireklarpwong, Supanat Kaeosuwan, Cholatip Wiratkapun, Sarunthorn Lapkittichot, Navalee Taerakul, Muntana Trimankha, Kanitha Nimitkul, Wiriya Pipatsakulroj, Thongchai Sukarayothin, Monchai Leesombatpaiboon, Ronnarat Suvikapakornkul, Yodying Wasuthit","doi":"10.1097/MS9.0000000000002616","DOIUrl":"10.1097/MS9.0000000000002616","url":null,"abstract":"<p><strong>Background: </strong>Arm morbidity and postoperative complications following sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) are common problems in patients with breast cancer. The de-escalating axillary surgery is increasing; however, there is a lack of patients with suspicious nodes. This study aimed to reduce the need for SLNB in suspicious lymph node cases.</p><p><strong>Methods: </strong>A prospective cohort study of women with invasive breast cancer who underwent surgery between January 2021 and December 2022. The study included two cohorts: Cohort A comprised patients with stage cT1-2N0-1M0 cancer who planned upfront surgery, while Cohort B included patients with stages cT1-4N2M0, cT3-4N1M0, or cT1-2N0-1M0 who received neoadjuvant systemic treatment. During the study, a clip was inserted into the suspicious lymph node on imaging to determine whether it could serve as a sentinel node and potentially replace SLNB or reduce the need for axillary surgery.</p><p><strong>Result: </strong>In cohort A, 22 surgeries were performed, while in cohort B, seven surgeries were performed. The median follow-up time was 15 months. In cohort A, 71% of the patients had cN0 disease, while 28% had cN1 disease. A suspicious node correlated to a sentinel node was noted in 66.67% of cohort A. The false-negative rate (FNR) was 14.28%. However, when the clip node removal procedure was performed instead of the sentinel node procedure, the FNR was 10%.</p><p><strong>Conclusion: </strong>In early breast cancer, suspicious nodes in imaging studies could not currently represent sentinel lymph nodes, and the FNR was still high. Nevertheless, more studies with larger populations will provide a better understanding due to the limited number of patients.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"6936-6943"},"PeriodicalIF":1.7,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy revolutionizing primary biliary cholangitis treatment. Elafibranor (Iqirvo)公布:fda批准的突破性治疗革命性的原发性胆管炎治疗。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-17 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002672
Iqra Furqan Ahmed, Fatima Rizwan, Haleema Mansoor, Marc Fakhoury, Muzzamil Hussain Shaik, Fenil Gandhi, Christopher Belletieri
{"title":"Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy revolutionizing primary biliary cholangitis treatment.","authors":"Iqra Furqan Ahmed, Fatima Rizwan, Haleema Mansoor, Marc Fakhoury, Muzzamil Hussain Shaik, Fenil Gandhi, Christopher Belletieri","doi":"10.1097/MS9.0000000000002672","DOIUrl":"10.1097/MS9.0000000000002672","url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"6910-6912"},"PeriodicalIF":1.7,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of high-dose olanzapine poisoning in a young child under limited resource setting: a case report from Nepal. 资源有限条件下幼儿大剂量奥氮平中毒的处理:尼泊尔一例报告。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-16 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002652
Pramodman Singh Yadav, Popular Pokhrel, Sashank Bhattarai, Pratik Adhikari, Abinash Dev, Aishworya Upadhaya, Shipra Chaudhary
{"title":"Management of high-dose olanzapine poisoning in a young child under limited resource setting: a case report from Nepal.","authors":"Pramodman Singh Yadav, Popular Pokhrel, Sashank Bhattarai, Pratik Adhikari, Abinash Dev, Aishworya Upadhaya, Shipra Chaudhary","doi":"10.1097/MS9.0000000000002652","DOIUrl":"10.1097/MS9.0000000000002652","url":null,"abstract":"<p><strong>Introduction: </strong>Olanzapine, an atypical antipsychotic, is widely used for treating psychiatric conditions such as schizophrenia and bipolar disorder. Accidental overdose in children is rare but can lead to severe clinical effects. This case report discusses the management of a 5-year-old male who accidently ingested 180 mg of olanzapine, the highest reported dose in a child around 5 year.</p><p><strong>Case presentation: </strong>A 5-year-old boy accidentally ingested 180 mg of Olanzapine, resulting in loss of consciousness and central nervous system depression. He exhibited hyperglycemia, elevated lactate, and prolonged prothrombin time, but no significant cardiovascular issues. Following intubation and supportive care, including intravenous medications and mechanical ventilation, the child gradually improved. He was discharged in stable condition with follow-up instructions.</p><p><strong>Discussion: </strong>Olanzapine toxicity in children presents with a variety of symptoms, including somnolence, hypotension, and neurological impairments, which are dose-dependent. Even in case of an exceptionally high overdose, the absence of cardiovascular toxicity supports safety profile of olanzapine. Common laboratory findings include hyperglycemia, elevated liver enzymes, and metabolic disturbances. Management involves airway protection, supportive care, and monitoring, as no specific antidote exists. Prompt and appropriate care, even in severe cases under limited resource settings, can lead to favorable outcomes.</p><p><strong>Conclusion: </strong>In cases of high-dose accidental olanzapine poisoning in children, it is essential to begin quick intervention and comprehensive supportive care to achieve successful outcomes and can be managed even in limited resource settings. Preventive measures are crucial to avoid such incidents, and careful monitoring is essential in managing pediatric olanzapine overdose.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7381-7384"},"PeriodicalIF":1.7,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the state of surgical care In Kenya: challenges, opportunities, and future directions. 解决肯尼亚外科护理状况:挑战、机遇和未来方向。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-16 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002667
Piel P Kuol, Peter N Wambu, Ruth W Mwangi, Bartay Matui, Alvin Kiprop, Kevin S Sokoto, Emmanuel Gudu
{"title":"Addressing the state of surgical care In Kenya: challenges, opportunities, and future directions.","authors":"Piel P Kuol, Peter N Wambu, Ruth W Mwangi, Bartay Matui, Alvin Kiprop, Kevin S Sokoto, Emmanuel Gudu","doi":"10.1097/MS9.0000000000002667","DOIUrl":"10.1097/MS9.0000000000002667","url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"6913-6915"},"PeriodicalIF":1.7,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of the FGF19 analog aldafermin for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis. 治疗非酒精性脂肪性肝炎的 FGF19 类似物 aldafermin 的疗效和安全性:经 GRADE 评估的系统综述和荟萃分析。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-16 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002649
Mohammad Haris Ali, Obaid Ur Rehman, Muhammad Talha, Eeshal Fatima, Laveeza Fatima, Ahmad Zain, Md Al Haisbuzzaman
{"title":"Efficacy and safety of the FGF19 analog aldafermin for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis.","authors":"Mohammad Haris Ali, Obaid Ur Rehman, Muhammad Talha, Eeshal Fatima, Laveeza Fatima, Ahmad Zain, Md Al Haisbuzzaman","doi":"10.1097/MS9.0000000000002649","DOIUrl":"10.1097/MS9.0000000000002649","url":null,"abstract":"<p><strong>Background: </strong>Nonalcoholic fatty liver disease (NAFLD) is increasingly concerning due to its rising prevalence. It encompasses conditions from simple steatosis to severe nonalcoholic steatohepatitis (NASH), posing risks such as fibrosis, cirrhosis, or hepatocellular carcinoma if untreated. This systematic review and meta-analysis aims to assess aldafermin, an FGF19 analog, for efficacy and safety in NASH patients.</p><p><strong>Methods: </strong>Eligible studies were identified by searching PubMed, Cochrane Library, and Google Scholar, resulting in 1115 studies. Three RCTs were included. The risk of bias was assessed using the Cochrane Risk of Bias tool, and data synthesis utilized Review Manager software. The certainty of evidence was evaluated with the GRADE approach.</p><p><strong>Results: </strong>In the 3 mg dose group, aldafermin significantly improved various parameters. The ELF score decreased notably (pooled MD: -0.46, 95% CI: -0.64 to -0.28; <i>P</i><0.00001). Additionally, fibrosis improvement without NASH worsening showed a pooled MD of 8.15 (95% CI: -3.62 to 19.93; <i>P</i><0.17), and fibrosis improvement with NASH resolution displayed a pooled MD of 10.16 (95% CI: 1.68-18.64; <i>P</i>=0.02). Furthermore, significant reductions were noted in absolute AST levels (pooled MD: -13.40, 95% CI: -18.66 to -8.14; <i>P</i><0.00001) and absolute ALT levels (pooled MD: -19.92, 95% CI: -27.08 to -12.75; <i>P</i><0.00001), suggesting improved liver function.</p><p><strong>Conclusion: </strong>The meta-analysis indicates that aldafermin, particularly, the 3 mg dose, shows significant efficacy in improving liver histology and biochemical markers in NASH patients compared to placebo, along with a satisfactory safety profile.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7072-7081"},"PeriodicalIF":1.7,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GATA1 transcription factor targets the gene expression of B19 virus in HEK293 cell line. GATA1转录因子靶向B19病毒在HEK293细胞系中的基因表达。
IF 1.7
Annals of Medicine and Surgery Pub Date : 2024-10-16 eCollection Date: 2024-12-01 DOI: 10.1097/MS9.0000000000002244
Amir Atashi, Leila Jafaripour, Kobra Froughi, Mahin Behzadifard
{"title":"GATA1 transcription factor targets the gene expression of B19 virus in HEK293 cell line.","authors":"Amir Atashi, Leila Jafaripour, Kobra Froughi, Mahin Behzadifard","doi":"10.1097/MS9.0000000000002244","DOIUrl":"10.1097/MS9.0000000000002244","url":null,"abstract":"<p><strong>Background/aim: </strong>B19 virus (B19V) is a single-strand DNA virus that has specific tropism to erythroid progenitor cells (EPCs). The virus enters the cells via P antigen and coreceptors and induces infection and cell apoptosis. GATA1 has a high expression in EPC and is a critical transcription factor for the cells development and differentiation. As human EPCs are the main target of the virus infection that have high expression of GATA-1 as the critical transcription factor, the aim of this study was to investigate the effect of GATA1 cotransfection with B19V genome on the expression of the viral mRNAs in HEK293 as nonpermissive cell line to the virus that had no mRNA expression of GATA-1.</p><p><strong>Methods: </strong>HEK293 cells were transfected with pHI0 plasmid containing the B19V genome and the plasmid of the GATA1 genome. The quantity of B19V mRNAs (NS1, 7.5 kDa, and 11 kDa) expression was evaluated after 24 h of transfection.</p><p><strong>Results: </strong>The results showed a statistically significant increase in fold change expression of (NS1 ∽12.3, VP1 ∽27.6, 11kb protein ∽38) in cotransfected cells with GATA1 and B19 plasmids compare to control group (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>This research showed transfected cells with GATA1 had elevation in the expression of the B19V genes mRNAs in a nonpermissive cell. This result may show the role of GATA1 as a critical transcription factor in support of the virus infection in EPCs. This suggests that GATA1 may potentially sport B19V replication or gene expression.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 12","pages":"7120-7124"},"PeriodicalIF":1.7,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信